News & Articles

Glox Therapeutics, involved in the development of precision antibiotic therapies based on naturally occurring bacteriocins, announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy).

Highlighting the impact of ctDNA and NGS for advancing cancer diagnostics and personalized treatment

Find out how CLINICAL24 supporter, the IBMS, has been addressing challenges for biomedical scientists through training, education, and advocacy for over 100 years

This collaboration brings new possibilities for consistent, high-purity cfDNA isolation

Sapio Sciences, the science-aware™ lab informatics platform, has entered a co-marketing agreement with Waters Corporation to enhance data integrity, workflow efficiency, and laboratory productivity

Explore CN Bio's innovative gut/liver-on-a-chip solution, empowering researchers to accurately profile human oral drug bioavailability in vitro

This new development will allow mRNA therapies to be manufactured in Poland for drug developers to treat COVID, potential forms of cancer, and more

Attend this expert webinar to stay ahead of the latest technological breakthroughs in the monoclonal gammopathy field

Research results highlight how the Idylla™ System allows for the analysis of small biological samples, including cytological specimens, giving healthcare providers critical information within hours so they can make timely treatment decisions

New guidelines for SARS-CoV-2 genomic surveillance aim to standardize NGS practices

New proprietary assembly technology pairs with groundbreaking complex DNA synthesis platform to deliver sequence-perfect clonal DNA as long as 5 kb

Promega and QuantumCyte sign co-marketing agreement aimed at enhancing the workflow solutions available to clinical laboratories

Learn how biomarkers can be used to transform drug approval and patient management in neurodegenerative medicine

inCerebro enhances CDD's capabilities in managing, sharing, and analysing complex research data, from its proprietary inCerebro MIND platform (Modelling with Intelligence for Novel Drugs).

Guest editorial by Arindam Ghosh, MBBS, PhD, a physician-scientist by training with extensive experience in neurodegenerative and neuropsychiatric disorders, particularly Alzheimer’s disease and dementia

Guest editorial by Mark Holland, Ph.D. Director, Bioinformatics/Biostatistics for Chemistry and Immunoassay Research and Development, Beckman Coulter

Explore how CLINICAL24 Ambassador, Dr. Vasiliki E. Kalodimou, is leveraging flow cytometry to revolutionize treatments with stem cells and regenerative medicine

nRichDX to unveil advanced liquid biopsy solutions at AMP 2024, showcasing high-yield sample prep innovations to enhance sensitivity in oncology diagnostics

ABLATOM deploys its LIBS microscope at the Grenoble Alpes University Hospital (CHUGA) to revolutionize patient diagnostics